CMP as on 24-Nov-20 10:06₹ 888.10
Turnover (lac)₹ 4,163
Prev. Close₹ 884.30
Day's Vol (shares)₹ 4,68,734
Day's Range (₹)
CMP as on24-Nov-20 10:06₹ 886.90
Turnover (lac)₹ 1,822
Prev. Close₹ 883.95
Day's Vol (shares)₹ 10,915
CMP as on 24-Nov-20 10:06₹ 887.90
Open Interest(Contracts)₹ 69,07,100
Day's Vol (shares)₹ 7,24,200
Day's Range (Ex.Dt. 26 Nov 2020)
14:36 IST, Nov 23
The index has also touched an intraday high of 11,835.65.
13:33 IST, Nov 18
The US drugmaker has filed a patent infringement case in the District of Delaware against Aurobindo in a district court.
15:09 IST, Nov 17
Pfizer Inc and its group companies have filed a petition against Aurobindo Pharma Ltd and Dr Reddys Laboratories in a US court.
15:00 IST, Nov 13
Of the total PLI scheme, an outlay of Rs15,000cr is set for pharmaceuticals and drugs sector.
15:06 IST, Nov 12
Tacrolimus Capsules USP are indicated for the prophylaxis of organ rejection in adult and pediatric patients.
13:26 IST, Nov 11
The sector limited losses in benchmarks Sensex and Nifty which have pared early gains and were trading flat led by selling in heavyweig
11:19 IST, Nov 11
Auto, healthcare and banking stocks were top performers, driving the benchmarks.
14:52 IST, Nov 10
Drugmaker Pfizer achieved success in the first interim analysis from the Phase 3 study.
10:00 IST, Nov 09
The inspection commenced on September 10, 2020, and concluded on November 5, 2020.
9:55 IST, Nov 09
Novel Laboratories concludes USFDA inspection with 13 observations